Cargando…

Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia

Preeclampsia and cardiovascular disease (CVD) share multiple features and risk factors. Circulating angiotensin-converting enzyme 2 (ACE2) is increased in CVD and mediates SARS-CoV-2 entry into host cells, causing COVID-19 infection. The role of ACE2 in preeclampsia pathophysiology is unknown. We hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Junus, Katja, Björk Ragnarsdóttir, Inger, Nordlöf Callbo, Paliz, Bergman, Lina, Lager, Susanne, Wikström, Anna-Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902901/ https://www.ncbi.nlm.nih.gov/pubmed/35260736 http://dx.doi.org/10.1038/s41598-022-08081-8

Ejemplares similares

Early Mid-pregnancy Blood-Based Proteins as Possible Biomarkers of Increased Infant Birth Size in Sex-Stratified Analyses
por: Lindberger, Emelie, et al.
Publicado: (2022)

Multi-Fetal Pregnancy, Preeclampsia, and Long-Term Cardiovascular Disease
por: Bergman, Lina, et al.
Publicado: (2020)

Study protocol: The cross-sectional Uppsala weight gain in pregnancy study (VIGA study)
por: Kallak, Theodora Kunovac, et al.
Publicado: (2023)

Waist Circumference Measurement for Prediction of Preeclampsia: A Population-Based Cohort Study
por: Pétursdóttir Maack, Heidrun, et al.
Publicado: (2021)

Alcohol exposure prior to pregnancy—does hazardous consumption affect placenta‐ and inflammatory‐mediated pregnancy outcomes? A Swedish population‐based cohort study
por: Asp, Joline, et al.
Publicado: (2022)

Association of Angiotensin-Converting Enzyme and Angiotensinogen Gene Polymorphisms with Preeclampsia
por: Choi, Hyunah, et al.
Publicado: (2004)

Elevated diastolic blood pressure until mid-gestation is associated with preeclampsia and small-for-gestational-age birth: a population-based register study
por: Gunnarsdottir, J., et al.
Publicado: (2019)

Plasma Levels of S100B in Preeclampsia and Association With Possible Central Nervous System Effects
por: Bergman, Lina, et al.
Publicado: (2014)

Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
por: Tamanna, Sonia, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme I/D Polymorphism and Preeclampsia Risk: Evidence of Small-Study Bias
por: Serrano, Norma C, et al.
Publicado: (2006)

Studies on Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Genotype Distributions in Turkish Preeclampsia Patients
por: Bereketoğlu, Ceyhun, et al.
Publicado: (2012)

Corrigendum: Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
por: Tamanna, Sonia, et al.
Publicado: (2021)

Study protocol: establishment of a multicentre pre-eclampsia database and biobank in Sweden: GO PROVE and UP MOST, a prospective cohort study
por: Thorgeirsdottir, Lilja, et al.
Publicado: (2021)

South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia
por: Reddy, Rebecca, et al.
Publicado: (2022)

Circulating Chemerin Is Elevated in Women With Preeclampsia
por: Bartho, Lucy A, et al.
Publicado: (2023)

Matrix metalloproteinase-2 is elevated in midtrimester amniotic fluid prior to the development of preeclampsia
por: Lavee, Michal, et al.
Publicado: (2009)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Ultrasound estimated subcutaneous and visceral adipose tissue thicknesses and risk of pre-eclampsia
por: Pétursdóttir Maack, Heidrun, et al.
Publicado: (2021)

Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia
por: Liu, Chen, et al.
Publicado: (2015)

Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis
por: Shah, Mitesh, et al.
Publicado: (2014)

Diagnostic value of elevated serum angiotensin-converting enzyme and lymphopenia in patients with granulomatous hepatitis
por: El Jammal, Thomas, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme Inhibitor Therapy Effects in Patients With Heart Failure With Preserved and Mid-Range Ejection Fraction
por: Safonova, Julia, et al.
Publicado: (2021)

Association of maternal central adiposity measured by ultrasound in early mid pregnancy with infant birth size
por: Lindberger, Emelie, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Author Correction: Association of maternal central adiposity measured by ultrasound in early mid pregnancy with infant birth size
por: Lindberger, Emelie, et al.
Publicado: (2022)

Circulating plasma angiotensin-converting enzyme 2 concentration is elevated in patients with kidney disease and diabetes
por: Sama, Iziah E, et al.
Publicado: (2020)

Prognostic value of elevated plasma angiotensin-converting enzyme 2 in cardiometabolic diseases: A review
por: Zhou, Gang, et al.
Publicado: (2023)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Association of Angiotensin-Converting Enzyme Intron 16 Insertion/Deletion and Angiotensin II Type 1 Receptor A1166C Gene Polymorphisms with Preeclampsia in South East of Iran
por: Salimi, Saeedeh, et al.
Publicado: (2011)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Editorial: Preeclampsia and the brain: Pre-clinical and clinical studies of cerebral involvement in preeclampsia
por: Bergman, Lina, et al.
Publicado: (2023)

Angiotensin converting enzime inhibitors : past, present and beyond /
Publicado: (1989)

Cerebral Biomarkers and Blood-Brain Barrier Integrity in Preeclampsia
por: Friis, Therese, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_479u92d9brd0auovkpf0l54g2c